Herpes zoster in women with and at risk for HIV: Data from the women's interagency HIV study

Journal of Acquired Immune Deficiency Syndromes

Volumn 37, Issue 5, 2004, Pages 1604-1609

  Glesby, Marshall J ^a   Hoover, Donald R ^b   Tan, Tianren ^c   Shi, Qiuhu ^d   Gao, Wei ^e   French, Audrey L ^f   Maurer, Toby ^g   Young, Mary ^h   DeHovitz, Jack ⁱ   Ru, Jenny ^j   Anastos, Kathryn ^e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c Data Solutions LLC   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e MONTEFIORE MEDICAL CENTER   (United States)

^f Jr Hospital of Cook County   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

ⁱ SUNY DOWNSTATE MEDICAL CENTER   (United States)

^j UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

more..

Author keywords

Epidemiology; Herpes zoster; HIV infection; Women

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HERPES ZOSTER; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL;

EID: 10644254546     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200412150-00013     Document Type: Article

References (18)

1. Tyndall MW, Nasio J, Agoki E, et al. Herpes zoster as the initial presentation of human immunodeficiency virus type 1 infection in Kenya. Clin Infect Dis. 1995;21:1035-1037.
2. Colebunders R, Mann JM, Francis H, et al. Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection. J Infect Dis. 1988;157:314-318.
3. Rogues A-M, Dupon M, Ladner J, et al. Herpes zoster and human immunodeficiency virus infection: a cohort study of 101 coinfected patients. [letter] J Infect Dis. 1993;168:245.
4. Glesby MJ, Moore RD, Chaisson RE. Zidovudine Epidemiology Study Group. Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. J Infect Dis. 1993;168:1264-1268.
5. Buchbinder SP, Katz MH, Hessol NA, et al. Herpes zoster and human immunodeficiency virus infection. J Infect Dis. 1992;166:1153-1156.
6. Morgan D, Mahe C, Malamba S, et al. Herpes zoster and HIV-1 infection in a rural Ugandan cohort. AIDS. 2001;15:223-229.
7. Engels EA, Rosenberg PS, Biggar RJ. Zoster incidence in human immunodeficiency virus-infected hemophiliacs and homosexual men, 1984-1997. District of Columbia Gay Cohort Study. Multicenter Hemophilia Cohort Study. J Infect Dis. 1999;180:1784-1789.
8. Veenstra J, Krol A, van Praag RME, et al. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS. 1995;9:1153-1158.
9. Aldeen T, Hay P, Davidson F, et al. Herpes zoster infection in HIV-seropositive patients associated with highly active antiretroviral therapy. [letter] AIDS. 1998;12:1719-1720.
10. Martinez E, Gatell J, Moran Y, et al. High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis. 1998;27:1510-1513.
11. Domingo P, Torres OH, Ris J, et al. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection. Am J Med. 2001;110:605-609.
12. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women' s Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology. 1998;9:117-125.
13. Dybul M, Fauci AS, Bartlett JG, et al. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med. 2002;137:381-433.
14. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
15. Rastogi R, Polydefkis MJ, Moore RD, et al. The incidence of herpes zoster among HIV patients in the post-HAART era [abstract 690]. In: Program and Abstracts of the 10th Conference on Retroviruses and Opportunistic Infections; February 10-14, 2003; Boston, MA.
16. Glesby MJ, Moore RD, Chaisson RE. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis. 1995;21:370-375.
17. Schmader K, George LK, Newton R, et al. The accuracy of self-report of herpes zoster. J Clin Epidemiol. 1994;47:1271-1276.
18. Veenstra J, van Praag RME, Krol A, et al. Complications of varicella zoster virus reactivation in HIV-infected homosexual men. AIDS. 1996;10:393-399.